SNO 2020: Adding Bevacizumab to Reradiation Confers a Survival Benefit in Recurrent GBM
No recommendations exist for relapsed glioblastoma.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.